Loading organizations...

§ Private Profile · Denver, CO, USA
Lin Health is a technology company.
Lin Health delivers an online chronic pain recovery program, employing an evidence-based, integrated care model. It combines personalized coaching with medical supervision through its physician network. This multidisciplinary approach blends behavioral health, physical therapy, and pain management, applying brain science to retrain neurological responses for relief.
Co-founded by CEO Yehuda Kogan, Lin Health launched in late 2021. Kogan, an experienced health tech entrepreneur, established the firm on the insight that many chronic pain conditions, resistant to conventional therapies, can managed through an integrated, brain-based care approach, shaping their distinct recovery platform.
Lin Health serves individuals with chronic pain, those unresponsive to traditional medical interventions. It partners with healthcare providers and payers to expand program access. The company’s vision is to redefine pain management, offering a compassionate, low-risk, accessible solution that empowers patients to regain function and improve quality of life.
Lin Health has raised $16.0M across 2 funding rounds.
Lin Health has raised $16.0M in total across 2 funding rounds.
Lin Health has raised $16.0M in total across 2 funding rounds.
Lin Health's investors include Dan Goldsmith, Mayo Clinic, NewHealth Ventures, Osage Venture Partners, Saban Ventures, Shoni Top Ventures, Viola Ventures, Altair Capital Management, Btomorrow Ventures, Fuel Ventures, Richard Longhurst.
Lin Health is a digital health technology company that provides evidence-based chronic pain treatment through a collaborative care model powered by proprietary technology. It partners with providers and payers to deliver personalized, low-risk care alternatives to opioids, targeting the nervous system with multidisciplinary coaching, digital resources, and clinical guidance to achieve lasting pain relief.[1][2] Serving patients suffering from chronic primary pain—affecting one in five Americans—the platform solves the problem of persistent pain by addressing bio-psycho-social factors rather than tissue damage, using techniques validated under the ICD-11 framework; it offers quick access (within days), insurance coverage (including Medicare and most major plans), and high outcomes like 98% improvement and 75% achieving pain-free or nearly pain-free status.[1][2] Growth momentum includes an $11M funding raise to scale its digital platform, which pairs patients with recovery coaches for tailored plans.[3]
Lin Health emerged to address the chronic pain crisis, with a mission to reclaim lives using the latest pain neuroscience and behavioral health advancements via the Collaborative Care model.[1] While specific founders are not detailed in available sources, the company is guided by a leadership team and a Clinical Advisory Panel, including experts like Dr. Shaheen Lakhan, MD, who contributed to the ICD-11 chronic primary pain code that underpins their approach.[1][2] Early traction stems from patient testimonials of years-long relief after failed traditional treatments, positioning Lin as a pioneer in nervous system signaling techniques for the 80% of persistent pain cases now classified under ICD-11.[2] Pivotal moments include clinical validation of their interventions and partnerships with health plans, enabling rapid scaling.[1][2][3]
Lin Health rides the wave of digital health innovations in pain management, shifting from opioid reliance to non-pharmacological, neuroscience-backed interventions amid the U.S. chronic pain epidemic affecting 20% of adults.[1][2] Timing aligns with ICD-11's reclassification of primary chronic pain, enabling validated, scalable digital solutions over outdated tissue-damage models.[2] Market forces like payer demands for cost-effective, covered care, provider burnout, and post-opioid crisis reforms favor Lin's model, which integrates with existing systems to expand access without silos.[1][2] It influences the ecosystem by pioneering collaborative digital platforms, improving outcomes, satisfaction, and clinic efficiency while setting a standard for bio-psycho-social pain tech.[2][3]
Lin Health is poised to expand its $11M-funded platform, deepening integrations with payers and providers to capture more of the massive chronic pain market.[3] Trends like AI-enhanced coaching, broader ICD-11 adoption, and value-based care will accelerate growth, potentially positioning it as a leader in preventive behavioral health tech. Its influence may evolve by standardizing nervous system-focused pain recovery, reducing societal opioid burdens and inspiring similar models in mental health—reclaiming lives at scale, as its mission promises.[1][2][3]
Lin Health has raised $16.0M across 2 funding rounds. Most recently, it raised $11.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 9, 2025 | $11M Series A | DAN Goldsmith | Mayo Clinic, Newhealth Ventures, Osage Venture Partners, Saban Ventures, Shoni TOP Ventures, Viola Ventures | Announced |
| Feb 1, 2024 | $5M Series A | — | Altair Capital Management, Btomorrow Ventures, Fuel Ventures, Viola Ventures, Richard Longhurst | Announced |